| scholarly article | Q13442814 |
| P50 | author | Stephanie Filleur | Q57022885 |
| Olga Volpert | Q70459087 | ||
| P2093 | author name string | Wuhan Xiao | |
| Zhou Wang | |||
| Arin Aurora | |||
| Yelena Mirochnik | |||
| Dorina Veliceasa | |||
| Alexander Yemelyanov | |||
| Irina Budunova | |||
| Thomas Nelius | |||
| E Shroff | |||
| P2860 | cites work | Human prostate tumor growth in athymic mice: inhibition by androgens and stimulation by finasteride | Q24603802 |
| Akt suppresses androgen-induced apoptosis by phosphorylating and inhibiting androgen receptor | Q24631156 | ||
| Caveolin-1 interacts with androgen receptor. A positive modulator of androgen receptor mediated transactivation | Q28207711 | ||
| Mutual transcriptional interference between RelA and androgen receptor | Q28289361 | ||
| Resveratrol inhibits the expression and function of the androgen receptor in LNCaP prostate cancer cells | Q28377926 | ||
| Prostatic intraepithelial neoplasia in mice expressing an androgen receptor transgene in prostate epithelium | Q28508802 | ||
| Pigment epithelium–derived factor regulates the vasculature and mass of the prostate and pancreas | Q28513340 | ||
| Androgens repress the expression of the angiogenesis inhibitor thrombospondin-1 in normal and neoplastic prostate | Q28568984 | ||
| Suppression of prostate tumor growth by U19, a novel testosterone-regulated apoptosis inducer | Q28587720 | ||
| Missing pieces in the NF-kappaB puzzle | Q29547864 | ||
| Identification of a negative regulatory cis-element in the enhancer core region of the prostate-specific antigen promoter: implications for intersection of androgen receptor and nuclear factor-kappaB signalling in prostate cancer cells | Q30312189 | ||
| Hormone status selects for spontaneous somatic androgen receptor variants that demonstrate specific ligand and cofactor dependent activities in autochthonous prostate cancer. | Q31527864 | ||
| Nuclear Factor- B Nuclear Localization Is Predictive of Biochemical Recurrence in Patients with Positive Margin Prostate Cancer | Q58325241 | ||
| Androgen-dependent cell cycle arrest and apoptotic death in PC-3 prostatic cell cultures expressing a full-length human androgen receptor | Q60594517 | ||
| DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction | Q70545330 | ||
| Hormonal therapy of prostatic cancer | Q71180374 | ||
| Overview of phase III trials on combined androgen treatment in patients with metastatic prostate cancer | Q72636487 | ||
| Androgen receptor--an update of mechanisms of action in prostate cancer | Q73022298 | ||
| Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer | Q73179856 | ||
| Vascular endothelial growth factor-A expression in the rat ventral prostate gland and the early effects of castration | Q73747740 | ||
| Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats | Q74117283 | ||
| Thrombospondin-1, vascular endothelial growth factor and fibroblast growth factor-2 are key functional regulators of angiogenesis in the prostate | Q77359737 | ||
| The role of IKK in constitutive activation of NF-kappaB transcription factor in prostate carcinoma cells | Q77522595 | ||
| Mutations in the androgen receptor gene are associated with progression of human prostate cancer to androgen independence | Q77556556 | ||
| Hypoxia induces pivotal tumor angiogenesis control factors including p53, vascular endothelial growth factor and the NFkappaB-dependent inducible nitric oxide synthase and cyclooxygenase-2 | Q78237675 | ||
| Androgen Receptors in Prostate Cancer | Q79075118 | ||
| Constitutive activation of P I3 K-Akt and NF-kappaB during prostate cancer progression in autochthonous transgenic mouse model | Q81403589 | ||
| Mutation of the androgen receptor causes oncogenic transformation of the prostate | Q33732154 | ||
| A tumor suppressor-dependent inhibitor of angiogenesis is immunologically and functionally indistinguishable from a fragment of thrombospondin | Q33763790 | ||
| Interleukin-6 and prostate cancer progression | Q33943225 | ||
| Haploinsufficiency of the Pten tumor suppressor gene promotes prostate cancer progression | Q33944717 | ||
| The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions | Q33961658 | ||
| Androgen receptor acetylation governs trans activation and MEKK1-induced apoptosis without affecting in vitro sumoylation and trans-repression function | Q34125103 | ||
| Androgen and its receptor promote Bax-mediated apoptosis | Q34519663 | ||
| Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches | Q34997082 | ||
| The role of the androgen receptor in prostate cancer | Q35008101 | ||
| Deregulated expression of insulin-like growth factor 1 in prostate epithelium leads to neoplasia in transgenic mice | Q35112453 | ||
| The androgen receptor: structure, mutations, and antiandrogens | Q35193278 | ||
| Mitogenic action of the androgen receptor sensitizes prostate cancer cells to taxane-based cytotoxic insult | Q35645461 | ||
| Genetically defined mouse models that mimic natural aspects of human prostate cancer development | Q35784138 | ||
| Survey of genetically engineered mouse models for prostate cancer: analyzing the molecular basis of prostate cancer development, progression, and metastasis | Q35964278 | ||
| A serum response element and a binding site for NF-Y mediate the serum response of the human thrombospondin 1 gene. | Q38321010 | ||
| Nuclear factor-kappaB is constitutively activated in prostate cancer in vitro and is overexpressed in prostatic intraepithelial neoplasia and adenocarcinoma of the prostate. | Q38337372 | ||
| Thrombospondin-1, vascular endothelial growth factor expression and their relationship with p53 status in prostate cancer and benign prostatic hyperplasia | Q38457725 | ||
| Angiogenesis and prostate cancer: in vivo and in vitro expression of angiogenesis factors by prostate cancer cells | Q38472948 | ||
| Serum basic fibroblast growth factor in men with and without prostate carcinoma | Q38479496 | ||
| Interleukin 1beta mediates the modulatory effects of monocytes on LNCaP human prostate cancer cells | Q39710081 | ||
| Evolution of the androgen receptor pathway during progression of prostate cancer. | Q40278784 | ||
| Dihydrotestosterone decreases tumor necrosis factor-alpha and lipopolysaccharide-induced inflammatory response in human endothelial cells. | Q40346017 | ||
| Androgen causes growth suppression and reversion of androgen-independent prostate cancer xenografts to an androgen-stimulated phenotype in athymic mice | Q40444201 | ||
| Requirement for NF-(kappa)B in interleukin-4-induced androgen receptor activation in prostate cancer cells. | Q40464312 | ||
| Interruption of nuclear factor kappaB signaling by the androgen receptor facilitates 12-O-tetradecanoylphorbolacetate-induced apoptosis in androgen-sensitive prostate cancer LNCaP cells | Q40617445 | ||
| Nerve growth factor induces the re-expression of functional androgen receptors and p75(NGFR) in the androgen-insensitive prostate cancer cell line DU145. | Q40706238 | ||
| Androgen induction of in vitro prostate cell differentiation. | Q40756224 | ||
| Androgen regulation of the cyclin-dependent kinase inhibitor p21 gene through an androgen response element in the proximal promoter | Q40821528 | ||
| Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest | Q41026724 | ||
| Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. | Q41086500 | ||
| Inhibition of NFkappaB activity through maintenance of IkappaBalpha levels contributes to dihydrotestosterone-mediated repression of the interleukin-6 promoter | Q41157776 | ||
| Androgen receptor gene amplification: a novel molecular mechanism for endocrine therapy resistance in human prostate cancer | Q41290323 | ||
| Nuclear factor kappa B functions as a negative regulator for the rat androgen receptor gene and NF-kappa B activity increases during the age-dependent desensitization of the liver | Q41380813 | ||
| Androgen-induced inhibition of cell proliferation in an androgen-insensitive prostate cancer cell line (PC-3) transfected with a human androgen receptor complementary DNA. | Q41565866 | ||
| A mechanism for hormone-independent prostate cancer through modulation of androgen receptor signaling by the HER-2/neu tyrosine kinase. | Q41615181 | ||
| Assay and purification of naturally occurring inhibitor of angiogenesis | Q41703789 | ||
| Androgen-induced differentiation and tumorigenicity of human prostate epithelial cells | Q42801295 | ||
| Characterization of prostatic epithelial cell lines derived from transgenic adenocarcinoma of the mouse prostate (TRAMP) model. | Q42815729 | ||
| Androgen induced cell death in SHSY5Y neuroblastoma cells expressing wild-type and spinal bulbar muscular atrophy mutant androgen receptors. | Q43596593 | ||
| Acquisition of agonistic properties of nonsteroidal antiandrogens after treatment with oncostatin M in prostate cancer cells. | Q44061938 | ||
| Pattern of somatic androgen receptor gene mutations in patients with hormone-refractory prostate cancer | Q44215058 | ||
| Endothelial cell proliferation in male reproductive organs of adult rat is high and regulated by testicular factors | Q44328811 | ||
| Androgens stimulate hypoxia-inducible factor 1 activation via autocrine loop of tyrosine kinase receptor/phosphatidylinositol 3'-kinase/protein kinase B in prostate cancer cells | Q44509691 | ||
| The PTEN tumor suppressor is a negative modulator of androgen receptor transcriptional activity | Q44546646 | ||
| Dihydrotestosterone promotes vascular cell adhesion molecule-1 expression in male human endothelial cells via a nuclear factor-kappaB-dependent pathway | Q44698960 | ||
| Independent association of angiogenesis index with outcome in prostate cancer | Q46071411 | ||
| Disruption of androgen receptor function inhibits proliferation of androgen-refractory prostate cancer cells. | Q52545397 | ||
| Androgen receptor mutations in prostate cancer. | Q54060047 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | prostate neoplasm | Q56014511 |
| P304 | page(s) | 999-1008 | |
| P577 | publication date | 2007-09-01 | |
| P1433 | published in | International Journal of Cancer | Q332492 |
| P1476 | title | Androgen receptor targets NFkappaB and TSP1 to suppress prostate tumor growth in vivo | |
| P478 | volume | 121 |
| Q90351679 | A review on the interactions between the tumor microenvironment and androgen receptor signaling in prostate cancer |
| Q34483490 | A screen for transcription factor targets of glycogen synthase kinase-3 highlights an inverse correlation of NFκB and androgen receptor signaling in prostate cancer |
| Q38985281 | Activation of nuclear factor κB pathway and downstream targets survivin and livin by SHARPIN contributes to the progression and metastasis of prostate cancer |
| Q50088636 | Androgen receptor dampens tissue factor expression via NF-κB and EGR1. |
| Q34189267 | Androgen receptor drives cellular senescence |
| Q33701358 | Coactivator MYST1 regulates nuclear factor-κB and androgen receptor functions during proliferation of prostate cancer cells |
| Q38743542 | Crosstalk between androgen and pro-inflammatory signaling remodels androgen receptor and NF-κB cistrome to reprogram the prostate cancer cell transcriptome. |
| Q37741773 | Differential androgen receptor signals in different cells explain why androgen-deprivation therapy of prostate cancer fails |
| Q35974731 | Differential targeting of androgen and glucocorticoid receptors induces ER stress and apoptosis in prostate cancer cells: a novel therapeutic modality |
| Q39285589 | Dissecting the roles of the androgen receptor in prostate cancer from molecular perspectives. |
| Q41967456 | Extracellular matrix proteins modulate antimigratory and apoptotic effects of Doxorubicin |
| Q33623369 | HES6 drives a critical AR transcriptional programme to induce castration-resistant prostate cancer through activation of an E2F1-mediated cell cycle network |
| Q34812703 | Identification of Enolase 1 and Thrombospondin-1 as serum biomarkers in HBV hepatic fibrosis by proteomics |
| Q57822873 | Identification of an IL-1-induced gene expression pattern in AR PCa cells that mimics the molecular phenotype of AR PCa cells |
| Q57107409 | Inflammation and NF-κB Signaling in Prostate Cancer: Mechanisms and Clinical Implications |
| Q37956492 | NF-κB signaling in prostate cancer: a promising therapeutic target? |
| Q42878519 | Negative regulation of the androgen receptor gene through a primate-specific androgen response element present in the 5' UTR. |
| Q36560660 | Neuronal androgen receptor regulates insulin sensitivity via suppression of hypothalamic NF-κB-mediated PTP1B expression. |
| Q34786941 | Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells |
| Q38161514 | Recent insights into NF-κB signalling pathways and the link between inflammation and prostate cancer |
| Q39771305 | Reduced tumor necrosis factor receptor-associated death domain expression is associated with prostate cancer progression |
| Q30410739 | Regulation of several androgen-induced genes through the repression of the miR-99a/let-7c/miR-125b-2 miRNA cluster in prostate cancer cells |
| Q51893327 | Reliability of a composite measure of social inclusion for people with psychiatric disabilities |
| Q38256290 | Sexual dimorphism in immunity: improving our understanding of vaccine immune responses in men. |
| Q37963916 | Therapies using anti-angiogenic peptide mimetics of thrombospondin-1. |
| Q38113142 | Thrombospondin-1 in urological cancer: pathological role, clinical significance, and therapeutic prospects |
| Q35098885 | Thrombospondin-1: multiple paths to inflammation |
| Q33604141 | Tumor suppressor U19/EAF2 regulates thrombospondin-1 expression via p53 |
| Q30474054 | Variants of the RELA gene are associated with schizophrenia and their startle responses |
| Q35082717 | miR-200b inhibits prostate cancer EMT, growth and metastasis |
Search more.